AVI files $75 million shelf

By Jennifer Chiou

New York, Oct. 30 - AVI BioPharma, Inc. registered to sell up to $75 million of securities in an S-3 filing with the Securities and Exchange Commission.

Covered by the shelf are common stock, preferred stock and warrants. Preferred stock may be structured as convertibles.

AVI said proceeds will go towards research and development and general corporate purposes.

The Portland, Ore.-based company develops therapeutic products using antisense drugs.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.